Facing a new increase in worldwide Malaria cases since 2015, a global technical strategy (GTS) has been implemented by the World Health Organization (WHO) aiming a decrease of 90% of Malaria impact by 2030.This requires the development of detection devices, very easy to use, collecting data and resistant to tropical conditions devoted to:• detect persistent undetectable parasitaemia in people without symptoms or recent history of malaria• detect the main causes of fever, whereof malaria• be a simplified control reference for other diagnostics

Facing a new increase in worldwide Malaria cases since 2015, a global strategy has been developed aiming a 90% decrease in Malaria exposure by 2030. This aim requires the development of a test devoted to detect persistant undetectable parasitaemia in people without symptoms or recent history of malaria.


Malaria pre-elimination and elimination


According to WHO: Malaria elimination is the interruption of local transmission (reduction to zero incidence of indigenous cases) of a specified malaria parasite species in a defined geographic area; continued measures are required to prevent re-establishment of transmission. WHO grants this certification when a country has proven, beyond reasonable doubt, that the chain of local transmission of all human malaria parasites has been interrupted nationwide for at least the past 3 consecutive years; and that a fully functional surveillance and response system that can prevent re-establishment of indigenous transmission is in place. Based on those requirements, the detection of circulating parasites in the whole population of an endemic country will be a cornerstone of the malaria elimination certification. There is no doubt that beyond the public health interest of such a certification, the economic and political impacts of becoming a malaria free country are huge.


Our products


Magnetrap develops Malaria detection tools for symptomatic and asymptomatic carriers considering as the heart of its activities the end users at the point-of-care.

Our solutions are based on several fields experience and a true knowledge of the needs for deseases detection. We ensure the long-term economical viability of the product and the whole value chain.

Low price by detection
Sensitivity
Tropicalisation
Easy to use
Data collection

The Advisory board

Management Team


Defeat malaria in a generation – here’s how (BBC)

https://www.bbc.com/news/health-49592468


Magnetrap has been selected in the EU Malaria Fund portfolio

As of June 20, 2019, Magnetrap has been selected as the only malaria diagnostic in the EU Malaria Fund portfolio. www.controlmalaria.eu


Magnetrap was awarded a subsidy of 1 million Euro by the Walloon Region

Magnetrap was awarded a subsidy of 1 million Euro by the Walloon Region on September, 4th 2018 to support its promising research on malaria detection devices.


Want to join us ?

Become a member of the team or Magnetrap's partner

Contact us

Want to join us ?

Become a member of the team or Magnetrap's partner

Contact us